Automated Molecular Diagnostics System Presented at AACC 2015
|
By LabMedica International staff writers Posted on 30 Jul 2015 |
A fully automated molecular diagnostics system has been presented that automatically performs nucleic acid extraction and purification from a large panel of biological specimens, amplification and detection of the nucleic acid extracted by reverse transcription polymerase chain reaction (RT-PCR), and result analysis.
The system automatically performs all the steps of molecular diagnostics including extraction, amplification and result analysis with one to 12 samples being processed with greater flexibility. The system offers the possibility to potentially mix any kind of sample matrices within the same run and perform multiple and independent PCR even with completely diverse thermal profiles simply on demand. In addition, each of the 12 real-time PCR thermal cyclers is equipped with six-optical channels, supplemented when appropriate with melt-curve analysis to provide extended multiplexing capability.
The system called of ELITe InGenius (ELITechGroup; Puteaux, France) in collaboration with Precision System Science, Co., Ltd. (PSS; Matsudo, Japan) is on the verge of receiving the upcoming Conformité Européenne – In Vitro Diagnostics (CE-IVD) marking for IVD applications in Europe and the upcoming availability of the instrument as Laboratory Use Equipment in the USA. The system is enabled with a unique real-time PCR menu based on ELITechGroup’s proven MGB technology, providing a rapid introduction of CE-IVD infectious disease menu for transplant monitoring and Healthcare Acquired Infections, also known as nosocomial infections. The versatile system can also be used as an open platform running laboratory developed tests or other tests of interest.
Christoph Gauer, CEO of ELITechGroup, said, “The launch of the ELITe InGenius system is a major step forward in our strategy to offer global solutions for Molecular Diagnostics. In partnership with PSS, we have taken advantage of decades of development expertise in molecular diagnostics chemistry and our proprietary real-time PCR menu to develop and validate a complete sample-to-result solution for infectious disease testing. The ELITe InGenius is a real breakthrough for molecular diagnostics. It combines unique capabilities not available on other sample-to-result systems, like universal extraction, storage of extracted nucleic acid and multiple and independently controlled RT-PCR with multiplexing capabilities, offering to the laboratory an unprecedented flexibility and assay menu possibility.” The ELITe InGenius system was shown at booth 2525 at the American Association of Clinical Chemistry (AACC) meeting held July 28–30, 2015, in Atlanta (GA, USA).
Related Links:
ELITechGroup
Precision System Science
American Association of Clinical Chemistry
The system automatically performs all the steps of molecular diagnostics including extraction, amplification and result analysis with one to 12 samples being processed with greater flexibility. The system offers the possibility to potentially mix any kind of sample matrices within the same run and perform multiple and independent PCR even with completely diverse thermal profiles simply on demand. In addition, each of the 12 real-time PCR thermal cyclers is equipped with six-optical channels, supplemented when appropriate with melt-curve analysis to provide extended multiplexing capability.
The system called of ELITe InGenius (ELITechGroup; Puteaux, France) in collaboration with Precision System Science, Co., Ltd. (PSS; Matsudo, Japan) is on the verge of receiving the upcoming Conformité Européenne – In Vitro Diagnostics (CE-IVD) marking for IVD applications in Europe and the upcoming availability of the instrument as Laboratory Use Equipment in the USA. The system is enabled with a unique real-time PCR menu based on ELITechGroup’s proven MGB technology, providing a rapid introduction of CE-IVD infectious disease menu for transplant monitoring and Healthcare Acquired Infections, also known as nosocomial infections. The versatile system can also be used as an open platform running laboratory developed tests or other tests of interest.
Christoph Gauer, CEO of ELITechGroup, said, “The launch of the ELITe InGenius system is a major step forward in our strategy to offer global solutions for Molecular Diagnostics. In partnership with PSS, we have taken advantage of decades of development expertise in molecular diagnostics chemistry and our proprietary real-time PCR menu to develop and validate a complete sample-to-result solution for infectious disease testing. The ELITe InGenius is a real breakthrough for molecular diagnostics. It combines unique capabilities not available on other sample-to-result systems, like universal extraction, storage of extracted nucleic acid and multiple and independently controlled RT-PCR with multiplexing capabilities, offering to the laboratory an unprecedented flexibility and assay menu possibility.” The ELITe InGenius system was shown at booth 2525 at the American Association of Clinical Chemistry (AACC) meeting held July 28–30, 2015, in Atlanta (GA, USA).
Related Links:
ELITechGroup
Precision System Science
American Association of Clinical Chemistry
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest AACC 2015 News
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
Hepatitis B virus (HBV) continues to pose a significant global health challenge, with chronic infection affecting hundreds of millions of people despite effective vaccines and antiviral therapies.... Read more
Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read moreMolecular Diagnostics
view channel
Hidden Genetic Subgroup Sheds New Light on Brain Tumors
Meningiomas are the most common primary tumors of the central nervous system and are typically treated with surgery or radiation, as targeted therapies remain limited. They account for more than one-third... Read more
Liquid Biopsy Approach Enhances Detection of Aggressive Breast Cancer Cells
Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer and lacks targeted therapies. It spreads more readily through the bloodstream, and metastasis is responsible for most breast... Read moreHematology
view channel
AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes
Alpha thalassemia affects millions of people worldwide and is especially common in regions such as Southeast Asia, where carrier rates can reach extremely high levels. While the condition can have significant... Read more
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channelAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read morePathology
view channel
Intraoperative Tumor Histology to Improve Cancer Surgeries
Surgical removal of cancer remains the first-line treatment for many tumors, but ensuring that all cancerous tissue is removed while preserving healthy tissue is a major challenge. Surgeons currently rely... Read more
Rapid Stool Test Could Help Pinpoint IBD Diagnosis
Inflammatory bowel disease (IBD) is a chronic condition in which the immune system mistakenly attacks the digestive tract, causing persistent gut inflammation. Diagnosis and disease monitoring often depend... Read more
AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery
Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read moreTechnology
view channelAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance... Read more









